List of Excipients in API ENTECAVIR
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing ENTECAVIR
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| ER Squibb & Sons LLC | BARACLUDE | entecavir | 0003-1611 | CELLULOSE, MICROCRYSTALLINE | |
| ER Squibb & Sons LLC | BARACLUDE | entecavir | 0003-1611 | CROSPOVIDONE | |
| ER Squibb & Sons LLC | BARACLUDE | entecavir | 0003-1611 | HYPROMELLOSE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing ENTECAVIR
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Teva Pharmaceuticals USA Inc | entecavir | 0093-5786 | CELLULOSE, MICROCRYSTALLINE |
| Teva Pharmaceuticals USA Inc | entecavir | 0093-5786 | CROSPOVIDONE |
| Teva Pharmaceuticals USA Inc | entecavir | 0093-5786 | MAGNESIUM STEARATE |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for ENTECAVIR
Excipient focus: CALCIUM CARBONATE
ENTECAVIR drug variants containing CALCIUM CARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | entecavir | 31722-833 |
| Cameron Pharmaceuticals | entecavir anhydrous | 42494-457 |
| >Company | >Ingredient | >NDC |
ENTECAVIR drug variants not containing CALCIUM CARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| ER Squibb & Sons LLC | entecavir | 0003-1611 |
| Teva Pharmaceuticals USA Inc | entecavir | 0093-5786 |
| Marlex Pharmaceuticals Inc | entecavir | 10135-615 |
| >Company | >Ingredient | >NDC |
Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM
ENTECAVIR drug variants containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | entecavir | 31722-833 |
| Cameron Pharmaceuticals | entecavir anhydrous | 42494-457 |
| >Company | >Ingredient | >NDC |
ENTECAVIR drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| ER Squibb & Sons LLC | entecavir | 0003-1611 |
| Teva Pharmaceuticals USA Inc | entecavir | 0093-5786 |
| Marlex Pharmaceuticals Inc | entecavir | 10135-615 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
ENTECAVIR drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| ER Squibb & Sons LLC | entecavir | 0003-1611 |
| Teva Pharmaceuticals USA Inc | entecavir | 0093-5786 |
| Marlex Pharmaceuticals Inc | entecavir | 10135-615 |
| >Company | >Ingredient | >NDC |
ENTECAVIR drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | entecavir | 31722-833 |
| Cameron Pharmaceuticals | entecavir anhydrous | 42494-457 |
| >Company | >Ingredient | >NDC |
Excipient focus: CITRIC ACID MONOHYDRATE
ENTECAVIR drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | entecavir | 31722-833 |
| Cameron Pharmaceuticals | entecavir anhydrous | 42494-457 |
| >Company | >Ingredient | >NDC |
ENTECAVIR drug variants not containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| ER Squibb & Sons LLC | entecavir | 0003-1611 |
| Teva Pharmaceuticals USA Inc | entecavir | 0093-5786 |
| Marlex Pharmaceuticals Inc | entecavir | 10135-615 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
ENTECAVIR drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| ER Squibb & Sons LLC | entecavir | 0003-1611 |
| Teva Pharmaceuticals USA Inc | entecavir | 0093-5786 |
| Marlex Pharmaceuticals Inc | entecavir | 10135-615 |
| >Company | >Ingredient | >NDC |
ENTECAVIR drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Accord Healthcare Inc | entecavir | 16729-388 |
| Camber Pharmaceuticals Inc | entecavir | 31722-833 |
| Sunshine Lake Pharma Co Ltd | entecavir | 48792-7891 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
ENTECAVIR drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| ER Squibb & Sons LLC | entecavir | 0003-1611 |
| EPIC PHARMA LLC | entecavir | 42806-658 |
| Pharmadax Inc | entecavir | 60050-057 |
| >Company | >Ingredient | >NDC |
ENTECAVIR drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | entecavir | 0093-5786 |
| Marlex Pharmaceuticals Inc | entecavir | 10135-615 |
| NorthStar RxLLC | entecavir | 16714-717 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
ENTECAVIR drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| NorthStar RxLLC | entecavir | 16714-717 |
| Yaopharma Co Ltd | entecavir | 50771-013 |
| Golden State Medical Supply Inc | entecavir | 51407-589 |
| >Company | >Ingredient | >NDC |
ENTECAVIR drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| ER Squibb & Sons LLC | entecavir | 0003-1611 |
| Teva Pharmaceuticals USA Inc | entecavir | 0093-5786 |
| Marlex Pharmaceuticals Inc | entecavir | 10135-615 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
ENTECAVIR drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | entecavir | 10135-615 |
| Accord Healthcare Inc | entecavir | 16729-388 |
| AvKARE | entecavir | 42291-261 |
| >Company | >Ingredient | >NDC |
ENTECAVIR drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| ER Squibb & Sons LLC | entecavir | 0003-1611 |
| Teva Pharmaceuticals USA Inc | entecavir | 0093-5786 |
| NorthStar RxLLC | entecavir | 16714-717 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
ENTECAVIR drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| ER Squibb & Sons LLC | entecavir | 0003-1611 |
| Marlex Pharmaceuticals Inc | entecavir | 10135-615 |
| NorthStar RxLLC | entecavir | 16714-717 |
| >Company | >Ingredient | >NDC |
ENTECAVIR drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | entecavir | 0093-5786 |
| Accord Healthcare Inc | entecavir | 16729-388 |
| Camber Pharmaceuticals Inc | entecavir | 31722-833 |
| >Company | >Ingredient | >NDC |
Excipient focus: LECITHIN, SOYBEAN
ENTECAVIR drug variants containing LECITHIN, SOYBEAN
ENTECAVIR drug variants not containing LECITHIN, SOYBEAN
| Company | Ingredient | NDC |
|---|---|---|
| ER Squibb & Sons LLC | entecavir | 0003-1611 |
| Teva Pharmaceuticals USA Inc | entecavir | 0093-5786 |
| Marlex Pharmaceuticals Inc | entecavir | 10135-615 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
ENTECAVIR drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| ER Squibb & Sons LLC | entecavir | 0003-1611 |
| Teva Pharmaceuticals USA Inc | entecavir | 0093-5786 |
| Marlex Pharmaceuticals Inc | entecavir | 10135-615 |
| >Company | >Ingredient | >NDC |
ENTECAVIR drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | entecavir | 31722-833 |
| Cameron Pharmaceuticals | entecavir anhydrous | 42494-457 |
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
ENTECAVIR drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | entecavir | 0093-5786 |
| >Company | >Ingredient | >NDC |
ENTECAVIR drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| ER Squibb & Sons LLC | entecavir | 0003-1611 |
| Marlex Pharmaceuticals Inc | entecavir | 10135-615 |
| NorthStar RxLLC | entecavir | 16714-717 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
ENTECAVIR drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | entecavir | 31722-833 |
| EPIC PHARMA LLC | entecavir | 42806-658 |
| American Health Packaging | entecavir | 60687-216 |
| >Company | >Ingredient | >NDC |
ENTECAVIR drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| ER Squibb & Sons LLC | entecavir | 0003-1611 |
| Teva Pharmaceuticals USA Inc | entecavir | 0093-5786 |
| Marlex Pharmaceuticals Inc | entecavir | 10135-615 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 3350
ENTECAVIR drug variants containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | entecavir | 0093-5786 |
| Solco Healthcare LLC | entecavir | 43547-436 |
| Sunshine Lake Pharma Co Ltd | entecavir | 48792-7891 |
| >Company | >Ingredient | >NDC |
ENTECAVIR drug variants not containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| ER Squibb & Sons LLC | entecavir | 0003-1611 |
| Marlex Pharmaceuticals Inc | entecavir | 10135-615 |
| NorthStar RxLLC | entecavir | 16714-717 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
ENTECAVIR drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| ER Squibb & Sons LLC | entecavir | 0003-1611 |
| Golden State Medical Supply Inc | entecavir | 51407-589 |
| Breckenridge Pharmaceutical Inc | entecavir | 51991-895 |
| >Company | >Ingredient | >NDC |
ENTECAVIR drug variants not containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | entecavir | 0093-5786 |
| Marlex Pharmaceuticals Inc | entecavir | 10135-615 |
| NorthStar RxLLC | entecavir | 16714-717 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 6000
ENTECAVIR drug variants containing POLYETHYLENE GLYCOL 6000
| Company | Ingredient | NDC |
|---|---|---|
| NorthStar RxLLC | entecavir | 16714-717 |
| Cipla USA Inc | entecavir | 69097-426 |
| >Company | >Ingredient | >NDC |
ENTECAVIR drug variants not containing POLYETHYLENE GLYCOL 6000
| Company | Ingredient | NDC |
|---|---|---|
| ER Squibb & Sons LLC | entecavir | 0003-1611 |
| Teva Pharmaceuticals USA Inc | entecavir | 0093-5786 |
| Marlex Pharmaceuticals Inc | entecavir | 10135-615 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 8000
ENTECAVIR drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | entecavir | 10135-615 |
| AvKARE | entecavir | 42291-261 |
| Amneal Pharmaceuticals LLC | entecavir | 65162-446 |
| >Company | >Ingredient | >NDC |
ENTECAVIR drug variants not containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| ER Squibb & Sons LLC | entecavir | 0003-1611 |
| Teva Pharmaceuticals USA Inc | entecavir | 0093-5786 |
| NorthStar RxLLC | entecavir | 16714-717 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
ENTECAVIR drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| ER Squibb & Sons LLC | entecavir | 0003-1611 |
| Camber Pharmaceuticals Inc | entecavir | 31722-833 |
| Breckenridge Pharmaceutical Inc | entecavir | 51991-895 |
| >Company | >Ingredient | >NDC |
ENTECAVIR drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | entecavir | 0093-5786 |
| Marlex Pharmaceuticals Inc | entecavir | 10135-615 |
| NorthStar RxLLC | entecavir | 16714-717 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
ENTECAVIR drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | entecavir | 0093-5786 |
| Solco Healthcare LLC | entecavir | 43547-436 |
| Sunshine Lake Pharma Co Ltd | entecavir | 48792-7891 |
| >Company | >Ingredient | >NDC |
ENTECAVIR drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| ER Squibb & Sons LLC | entecavir | 0003-1611 |
| Marlex Pharmaceuticals Inc | entecavir | 10135-615 |
| NorthStar RxLLC | entecavir | 16714-717 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
ENTECAVIR drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| ER Squibb & Sons LLC | entecavir | 0003-1611 |
| Marlex Pharmaceuticals Inc | entecavir | 10135-615 |
| NorthStar RxLLC | entecavir | 16714-717 |
| >Company | >Ingredient | >NDC |
ENTECAVIR drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | entecavir | 0093-5786 |
| Accord Healthcare Inc | entecavir | 16729-388 |
| Camber Pharmaceuticals Inc | entecavir | 31722-833 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
ENTECAVIR drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Solco Healthcare LLC | entecavir | 43547-436 |
| AvPAK | entecavir | 50268-289 |
| Golden State Medical Supply Inc | entecavir | 51407-589 |
| >Company | >Ingredient | >NDC |
ENTECAVIR drug variants not containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| ER Squibb & Sons LLC | entecavir | 0003-1611 |
| Teva Pharmaceuticals USA Inc | entecavir | 0093-5786 |
| Marlex Pharmaceuticals Inc | entecavir | 10135-615 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
ENTECAVIR drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Accord Healthcare Inc | entecavir | 16729-388 |
| Golden State Medical Supply Inc | entecavir | 51407-064 |
| >Company | >Ingredient | >NDC |
ENTECAVIR drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| ER Squibb & Sons LLC | entecavir | 0003-1611 |
| Teva Pharmaceuticals USA Inc | entecavir | 0093-5786 |
| Marlex Pharmaceuticals Inc | entecavir | 10135-615 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
ENTECAVIR drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Accord Healthcare Inc | entecavir | 16729-388 |
| Sunshine Lake Pharma Co Ltd | entecavir | 48792-7891 |
| Golden State Medical Supply Inc | entecavir | 51407-064 |
| >Company | >Ingredient | >NDC |
ENTECAVIR drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| ER Squibb & Sons LLC | entecavir | 0003-1611 |
| Teva Pharmaceuticals USA Inc | entecavir | 0093-5786 |
| Marlex Pharmaceuticals Inc | entecavir | 10135-615 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STEARYL FUMARATE
ENTECAVIR drug variants containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | entecavir | 31722-833 |
| Cameron Pharmaceuticals | entecavir anhydrous | 42494-457 |
| >Company | >Ingredient | >NDC |
ENTECAVIR drug variants not containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| ER Squibb & Sons LLC | entecavir | 0003-1611 |
| Teva Pharmaceuticals USA Inc | entecavir | 0093-5786 |
| Marlex Pharmaceuticals Inc | entecavir | 10135-615 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
ENTECAVIR drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | entecavir | 0093-5786 |
| Camber Pharmaceuticals Inc | entecavir | 31722-833 |
| Cameron Pharmaceuticals | entecavir anhydrous | 42494-457 |
| >Company | >Ingredient | >NDC |
ENTECAVIR drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| ER Squibb & Sons LLC | entecavir | 0003-1611 |
| Marlex Pharmaceuticals Inc | entecavir | 10135-615 |
| NorthStar RxLLC | entecavir | 16714-717 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, PREGELATINIZED CORN
ENTECAVIR drug variants containing STARCH, PREGELATINIZED CORN
| Company | Ingredient | NDC |
|---|---|---|
| Sunshine Lake Pharma Co Ltd | entecavir | 48792-7891 |
| >Company | >Ingredient | >NDC |
ENTECAVIR drug variants not containing STARCH, PREGELATINIZED CORN
| Company | Ingredient | NDC |
|---|---|---|
| ER Squibb & Sons LLC | entecavir | 0003-1611 |
| Teva Pharmaceuticals USA Inc | entecavir | 0093-5786 |
| Marlex Pharmaceuticals Inc | entecavir | 10135-615 |
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
ENTECAVIR drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | entecavir | 0093-5786 |
| Solco Healthcare LLC | entecavir | 43547-436 |
| Sunshine Lake Pharma Co Ltd | entecavir | 48792-7891 |
| >Company | >Ingredient | >NDC |
ENTECAVIR drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| ER Squibb & Sons LLC | entecavir | 0003-1611 |
| Marlex Pharmaceuticals Inc | entecavir | 10135-615 |
| NorthStar RxLLC | entecavir | 16714-717 |
| >Company | >Ingredient | >NDC |
Excipient focus: THIAMINE MONONITRATE
ENTECAVIR drug variants containing THIAMINE MONONITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | entecavir | 31722-833 |
| Cameron Pharmaceuticals | entecavir anhydrous | 42494-457 |
| >Company | >Ingredient | >NDC |
ENTECAVIR drug variants not containing THIAMINE MONONITRATE
| Company | Ingredient | NDC |
|---|---|---|
| ER Squibb & Sons LLC | entecavir | 0003-1611 |
| Teva Pharmaceuticals USA Inc | entecavir | 0093-5786 |
| Marlex Pharmaceuticals Inc | entecavir | 10135-615 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
ENTECAVIR drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| ER Squibb & Sons LLC | entecavir | 0003-1611 |
| Teva Pharmaceuticals USA Inc | entecavir | 0093-5786 |
| Marlex Pharmaceuticals Inc | entecavir | 10135-615 |
| >Company | >Ingredient | >NDC |
ENTECAVIR drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
ENTECAVIR drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Pharmadax Inc | entecavir | 60050-057 |
| Florida Pharmaceutical Products LLC | entecavir | 71921-194 |
| >Company | >Ingredient | >NDC |
ENTECAVIR drug variants not containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| ER Squibb & Sons LLC | entecavir | 0003-1611 |
| Teva Pharmaceuticals USA Inc | entecavir | 0093-5786 |
| Marlex Pharmaceuticals Inc | entecavir | 10135-615 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
ENTECAVIR drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Yaopharma Co Ltd | entecavir | 50771-013 |
| >Company | >Ingredient | >NDC |
ENTECAVIR drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| ER Squibb & Sons LLC | entecavir | 0003-1611 |
| Teva Pharmaceuticals USA Inc | entecavir | 0093-5786 |
| Marlex Pharmaceuticals Inc | entecavir | 10135-615 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
